These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32797103)

  • 41. Molecular cloning and characterization of APOBEC3 family in tree shrew.
    Luo MT; Fan Y; Mu D; Yao YG; Zheng YT
    Gene; 2018 Mar; 646():143-152. PubMed ID: 29292195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innate cellular defenses of APOBEC3 cytidine deaminases and viral counter-defenses.
    Yu XF
    Curr Opin HIV AIDS; 2006 May; 1(3):187-93. PubMed ID: 19372807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
    Chiu YL; Greene WC
    Annu Rev Immunol; 2008; 26():317-53. PubMed ID: 18304004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
    Russell RA; Wiegand HL; Moore MD; Schäfer A; McClure MO; Cullen BR
    J Virol; 2005 Jul; 79(14):8724-31. PubMed ID: 15994766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inhibition of hepatitis B virus by APOBEC cytidine deaminases.
    Janahi EM; McGarvey MJ
    J Viral Hepat; 2013 Dec; 20(12):821-8. PubMed ID: 24304451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
    Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution.
    Ou Z; Ouzounis C; Wang D; Sun W; Li J; Chen W; Marlière P; Danchin A
    Genome Biol Evol; 2020 Dec; 12(12):2467-2485. PubMed ID: 33125064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.
    Green AM; Weitzman MD
    DNA Repair (Amst); 2019 Nov; 83():102700. PubMed ID: 31563041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The APOBEC3B cytidine deaminase is an adenovirus restriction factor.
    Lejeune N; Mathieu S; Decloux A; Poulain F; Blockx Z; Raymond KA; Willemart K; Vartanian JP; Suspène R; Gillet NA
    PLoS Pathog; 2023 Feb; 19(2):e1011156. PubMed ID: 36745676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APOBEC3 inhibits mouse mammary tumour virus replication in vivo.
    Okeoma CM; Lovsin N; Peterlin BM; Ross SR
    Nature; 2007 Feb; 445(7130):927-30. PubMed ID: 17259974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective inhibition of APOBEC3 enzymes by single-stranded DNAs containing 2'-deoxyzebularine.
    Barzak FM; Harjes S; Kvach MV; Kurup HM; Jameson GB; Filichev VV; Harjes E
    Org Biomol Chem; 2019 Nov; 17(43):9435-9441. PubMed ID: 31603457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
    Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human T cell leukemia virus type I is resistant to the antiviral effects of APOBEC3.
    Ohsugi T; Koito A
    J Virol Methods; 2007 Jan; 139(1):93-6. PubMed ID: 17123636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins.
    Yoshikawa R; Nakano Y; Yamada E; Izumi T; Misawa N; Koyanagi Y; Sato K
    Microbiol Immunol; 2016 Apr; 60(4):272-9. PubMed ID: 26935128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deamination-independent restriction of LINE-1 retrotransposition by APOBEC3H.
    Feng Y; Goubran MH; Follack TB; Chelico L
    Sci Rep; 2017 Sep; 7(1):10881. PubMed ID: 28883657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.
    Izumi T; Shirakawa K; Takaori-Kondo A
    Mini Rev Med Chem; 2008 Mar; 8(3):231-8. PubMed ID: 18336343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deaminase-Independent Mode of Antiretroviral Action in Human and Mouse APOBEC3 Proteins.
    Hakata Y; Miyazawa M
    Microorganisms; 2020 Dec; 8(12):. PubMed ID: 33322756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms.
    Nitta T; Ha D; Galvez F; Miyazawa T; Fan H
    Retrovirology; 2015 Aug; 12():68. PubMed ID: 26253512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antiviral defense by APOBEC3 family proteins].
    Takaori A
    Uirusu; 2005 Dec; 55(2):267-72. PubMed ID: 16557012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate with the Viral Envelope as a Type I Integral Membrane Protein.
    Renner TM; Bélanger K; Lam C; Gerpe MCR; McBane JE; Langlois MA
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.